(Medical Xpress) -- Antidepressant medications such as Prozac have helped improve mood and lessen anxiety in millions of people with major depression. But scientists know surprisingly little about how these drugs work.
May 25, 2012
1
0
According to a group of geneticists in Switzerland from iGENEA, the DNA genealogy center, as many as half of all European men and 70 percent of British men share the same DNA as the Egyptian Pharaoh Tutankhamun, or King Tut.
A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient outcomes, according ...
Nov 14, 2023
0
0
Genetic risk factors for major depression (MD), bipolar disorder (BD), other nonaffective psychosis (ONAP), and schizophrenia are systematically associated with their diagnostic trajectories, according to a study published ...
Feb 22, 2023
0
2
Cancer cells have developed multiple mechanisms to thrive. One example, derived from age-old theories of evolution, is positive selection i.e., the propensity of cells with favorable cancer mutations to flourish. However, ...
Jan 18, 2023
0
12
A patient's tumor cell response to therapy is affected by many factors, including genetic alterations, tumor microenvironment, and intratumoral heterogeneity. This can make it extremely difficult to determine optimum treatment ...
May 5, 2022
0
10
A new study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has found that Black women with metastatic breast cancer were less likely to have tumors with treatable ...
Apr 25, 2022
0
58
Around 20,000 Swedes are currently suffering from Parkinson's disease, yet there are still only treatments to alleviate symptoms. Through a new biobank, researchers gain access to the genetic profiles of 1000 Parkinson's ...
May 26, 2021
0
3
The toxic protein tau is a key biological feature in the brains of people with Alzheimer's disease. Yet the factors that make people susceptible or resistant to tau accumulation are not well-understood. A preliminary Mayo ...
Mar 4, 2020
0
26
A questionnaire aimed at assessing how well community oncologists understand "molecular profiling" results from tumor specimens found that 69 percent of participants either said they don't know the answers, or they responded ...
May 30, 2019
0
0
